Name | ENDOMEDITSINA, OOO |
|---|
INN | 5260405030 |
|---|
KPP | 526001001 |
|---|
OGRN | 1155260001566 |
|---|
Address | 603005, Nizhegorodskaya Oblast', g. Nizhniy Novgorod, ul. Varvarskaya, d. D. 6A, of. OFIS 2 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 46.46 | Core activity | Wholesale of pharmaceutical goods | | 33.13 | Additional activity | Repair of electronic and optical equipment | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | All types of activities | | 52.29 | Additional activity | Service activities incidental to land transportation | | 68.20.2 | Additional activity | Renting and operating of own or leased commercial properties and non- residential buildings | | 70.22 | Additional activity | Advice on business and management |
Registration date | 10.02.2015 |
|---|
Registering department | Inspektsiya Federal'noy nalogovoy sluzhby po Nizhegorodskomu rayonu g.Nizhnego Novgoroda |
|---|
|
ENDOMEDITSINA, OOO (Nizhny Novgorod Oblast; INN 5260405030) was registered on 10 Feb 2015. The company's authorized capital as of July 1, 2012 was 10000 rub. Principal activities of ENDOMEDITSINA, OOO: wholesale of pharmaceutical goods (46.46), repair of electronic and optical equipment (33.13), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74). |
Economic indicators2023
Net profit (RAS) of ENDOMEDITSINA, OOO grew over 2023 by 44.32% to 89.85 million RUB from 62.26 million RUB over 2022, the company informed. Revenue increased in the accounting period 1.51 times to 387.50 million RUB from 256.79 million RUB over 2022; cost of goods sold grew by 46.06% to 242.22 million RUB from 165.84 million RUB; sales profit went up by 47.62% to 117.68 million RUB from 79.72 million RUB. 2022
Net profit (RAS) of ENDOMEDITSINA, OOO grew over 2022 1.58 times to 62.26 million RUB from 39.31 million RUB over 2021, the company informed. Revenue increased in the accounting period by 41.84% to 256.79 million RUB from 181.03 million RUB over 2021; cost of goods sold grew by 38.71% to 165.84 million RUB from 119.56 million RUB; sales profit went up 1.54 times to 79.72 million RUB from 51.89 million RUB. 2021
Net profit (RAS) of ENDOMEDITSINA, OOO dropped in 2021 by 15.91% to 39.31 million RUB from 46.74 million RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 11.95% to 181.03 million RUB from 205.59 million RUB in 2020; cost of goods sold decreased by 10.80% to 119.56 million RUB from 134.04 million RUB; sales profit fell by 16.15% to 51.89 million RUB from 61.88 million RUB. 2020
Net profit (RAS) of ENDOMEDITSINA, OOO dropped in 2020 by 11.81% to 46.74 million RUB from 53.00 million RUB over the same period in 2019, the company informed. Revenue decreased in the accounting period by 0.55% to 205.59 million RUB from 206.72 million RUB in 2019; cost of goods sold grew by 1.60% to 134.04 million RUB from 131.93 million RUB; sales profit fell by 9.57% to 61.88 million RUB from 68.43 million RUB. 2019
Net profit (RAS) of ENDOMEDITSINA, OOO dropped in 2019 by 1.41% to 53.00 million RUB from 53.76 million RUB over the same period in 2018, the company informed. Revenue increased in the accounting period by 13.29% to 206.72 million RUB from 182.48 million RUB over 2018; cost of goods sold grew by 19.74% to 131.93 million RUB from 110.18 million RUB; sales profit fell by 1.24% to 68.43 million RUB from 69.29 million RUB. 2018
Net profit (RAS) of ENDOMEDITSINA, OOO grew over 2018 by 37.81% to 53.76 million RUB from 39.01 million RUB over 2017, the company informed. Revenue increased in the accounting period by 45.10% to 182.48 million RUB from 125.76 million RUB over 2017; cost of goods sold grew 1.51 times to 110.18 million RUB from 73.07 million RUB; sales profit went up by 38.82% to 69.29 million RUB from 49.91 million RUB. 2017
Net profit (RAS) of ENDOMEDITSINA, OOO grew over 2017 by 33.86% to 39.01 million RUB from 29.14 million RUB over 2016, the company informed. Revenue increased in the accounting period by 9.38% to 125.76 million RUB from 114.97 million RUB over 2016; cost of goods sold decreased by 1.56% to 73.07 million RUB from 74.23 million RUB; sales profit went up by 37.23% to 49.91 million RUB from 36.37 million RUB. 2016
Net profit (RAS) of ENDOMEDITSINA, OOO grew over 2016 5.86 times to 29.14 million RUB from 4.98 million RUB over 2015, the company informed. Revenue increased in the accounting period 4.60 times to 114.97 million RUB from 25.01 million RUB over 2015; cost of goods sold grew 4.41 times to 74.23 million RUB from 16.82 million RUB; sales profit went up 5.79 times to 36.37 million RUB from 6.28 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|